Mouwasat Medical Services Company SJSC (4002)

Currency in SAR
58.00
+0.30(+0.52%)
Delayed Data·
High dividend Yield
4002 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
57.1058.25
52 wk Range
52.4573.95
Key Statistics
Bid/Ask
58.00 / 58.10
Prev. Close
57.7
Open
57.7
Day's Range
57.1-58.25
52 wk Range
52.45-73.95
Volume
124.51K
Average Volume (3m)
370.74K
1-Year Change
-17.3077%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4002 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Currently not supported.
Price Target
76.38
Upside
+31.69%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings upwards for the upcoming period
Show more

Analyst Ratings

6 Buy
6 Hold
1 Sell
Ratings:
13 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 76.38
(+31.69% Upside)

Earnings

Latest Release
Nov 02, 2026
EPS / Forecast
0.96 / 0.99
Revenue / Forecast
855.72M / 876.46M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.19
Dividend Yield
5.42%
Industry Median 2.42%
Annualized payout
3.13
Paid unevenly
5-Years Growth
+11.20%
Growth Streak

4002 Income Statement

Compare 4002 to Peers and Sector

Metrics to compare
4002
Peers
Sector
Relationship
P/E Ratio
13.8x16.0x−0.2x
PEG Ratio
1.250.170.00
Price/Book
2.8x1.7x2.6x
Price / LTM Sales
3.4x1.5x2.7x
Upside (Analyst Target)
31.4%32.5%66.0%
Fair Value Upside
Unlock26.4%10.8%Unlock

Mouwasat Medical Services Company, together with its subsidiaries, engages in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia. The company operates a network of hospitals that provides medical services and specialized centers, including eye, obesity, cardiology, diabetic, robotic, fertility, rehabilitation, long term care, stroke, and skincare center. It also provides various services comprising inpatient pharmacy services, TPN and IV medication preparation units, chemotherapy medication preparation, anti-coagulant clinic, and clinical pharmacy services. In addition, the company is involved in construction and operation of hospitals, dispensaries, and special clinics; general construction of non-residential buildings, including schools, hospitals, and hotels; demolition of buildings; purchase, sale, and division of land and real estate; off-plan sales activities; operation of colleges and university institutes; and medical operation of hospitals. Further, it wholesales medical equipment and drugs. Mouwasat Medical Services Company was founded in 1974 and is based in Dammam, the Kingdom of Saudi Arabia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
12.07M6.04%716.42M
Other Institutional Investors
34.90M17.45%2.07B
Public Companies & Retail Investors
153.02M76.51%9.08B
Total
200M100.00%11.87B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Estate of Mohammed Suleiman Al-Saleem17.50%35,000,0002,077,250
Vanguard Capital Management, LLC2.00%3,996,531237,194

People Also Watch

23.43
2050
+0.13%
14.56
2380
+0.55%
12.97
4321
-0.69%

FAQ

What Is the Mouwasat (4002) Stock Price Today?

The Mouwasat stock price today is 58.00 SAR.

What Stock Exchange Does Mouwasat Trade On?

Mouwasat is listed and trades on the Saudi Arabia Stock Exchange.

What Is the Stock Symbol for Mouwasat?

The stock symbol for Mouwasat is "4002."

Does Mouwasat Pay Dividends? What’s The Current Dividend Yield?

The Mouwasat dividend yield is 5.4%%.

What Is the Mouwasat Market Cap?

As of today, Mouwasat market cap is 11.63B SAR.

What Is Mouwasat's Earnings Per Share (TTM)?

The Mouwasat EPS (TTM) is 4.19.

When Is the Next Mouwasat Earnings Date?

Mouwasat will release its next earnings report on Mar 09, 2027.

How Many Times Has Mouwasat Stock Split?

Mouwasat has split 3 times.

How Many Employees Does Mouwasat Have?

Mouwasat has 2389 employees.

What is the current trading status of Mouwasat (4002)?

As of Nov 17, 2026, Mouwasat (4002) is trading at a price of 58.00 SAR, with a previous close of 57.70 SAR. The stock has fluctuated within a day range of 57.10 SAR to 58.25 SAR, while its 52-week range spans from 52.45 SAR to 73.95 SAR.

What Is Mouwasat (4002) Price Target According to Analysts?

The average 12-month price target for Mouwasat is 76.38 SAR, with a high estimate of 100 SAR and a low estimate of 57 SAR. 6 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +31.69% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.